[1] Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H, et al. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol 2019;4(2):135 − 84. http://dx.doi.org/10.1016/s2468-1253(18)30270-x.
[2] Zou ZY, Cini K, Dong B, Ma YH, Ma J, Burgner DP, et al. Time trends in cardiovascular disease mortality across the BRICS: an age-period-cohort analysis of key nations with emerging economies using the global burden of disease study 2017. Circulation 2020;141(10):790 − 9. http://dx.doi.org/10.1161/circulationaha.119.042864.
[3] Sun Y, Chang J, Liu X, Liu CJ. Mortality trends of liver diseases in mainland China over three decades: an age-period-cohort analysis. BMJ Open 2019;9(11):e029793. http://dx.doi.org/10.1136/bmjopen-2019-029793.
[4] Duan ZP, Jia JD, Hou JL, Lou L, Tobias H, Xu XY, et al. Current challenges and the management of chronic hepatitis C in mainland China. J Clin Gastroenterol 2014;48(8):679 − 86. http://dx.doi.org/10.1097/mcg.0000000000000109.
[5] Ren X, Wu P, Wang LP, Geng MJ, Zeng LJ, Zhang J, et al. Changing epidemiology of hepatitis A and hepatitis E viruses in China, 1990-2014. Emerg Infect Dis 2017;23(2):276 − 9. http://dx.doi.org/10.3201/2302.161095.
[6] Jacobsen H, Klein SL. Sex differences in immunity to viral infections. Front Immunol 2021;12:720952. http://dx.doi.org/10.3389/fimmu.2021.720952.
[7] Zheng XY, Luo YN, Su BB, He P, Guo C, Tian YH, et al. Developmental gerontology and active population aging in China. China CDC Wkly 2023;5(8):184 − 7. http://dx.doi.org/10.46234/ccdcw2023.033.
[8] Zheng XY, Guo C. Strengthening systematic research on aging: reflections from an omics perspective. China CDC Wkly 2022;4(39):875 − 8. http://dx.doi.org/10.46234/ccdcw2022.181.
[9] McMichael AJ. Environmental and social influences on emerging infectious diseases: past, present and future. Philos Trans Roy Soc B: Biol Sci 2004;359(1447):1049 − 58. http://dx.doi.org/10.1098/rstb.2004.1480.
[10] Gong ZY, Gao Y, Mao YP, Wang XL. The normalization of COVID-19 epidemic prevention and control calls for patriotic health campaign inherit and innovation. Dis Surveill 2022;37(9):1152 − 8. http://dx.doi.org/10.3784/jbjc.202207090330. (In Chinese).
[11] Cui Y, Jia JD. Update on epidemiology of hepatitis B and C in China. J Gastroenterol Hepatol 2013;28 Suppl 1:7-10. http://dx.doi.org/10.1111/jgh.12220.